Effect of two high intensity interval training and one moderate continuous training methods on apo B/apo A ratio and ABCA1, ABCG1 expression in CABG patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230529058327N1

Enrollment

Registered

2023-08-03

Start date

2022-04-21

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery bypass grafting. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Control group: They did not receive any special training. Intervention 2: Intervention group 1: moderate-intensity continuous training (MIT). They received continuous aerobic exercises

Eligibility

Sex/Gender

Male

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Coronary artery bypass grafting patient male At least two months have passed since their surgery.

Exclusion criteria

Exclusion criteria: Met less than 5 Injection fraction less than 30 blood pressure Arthritis

Design outcomes

Primary

Measure	Time frame
ATP-binding cassette transporter A1 (ABCA1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;ATP-binding cassette transporter B1 (ABCG1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;Apolipoprotein A-1 (apoA-1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;High-density lipoprotein (HDL). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;Apolipoprotein B (apoB-1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.	—

Measure

Time frame

ATP-binding cassette transporter A1 (ABCA1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;ATP-binding cassette transporter B1 (ABCG1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;Apolipoprotein A-1 (apoA-1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;High-density lipoprotein (HDL). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.;Apolipoprotein B (apoB-1). Timepoint: before the start of the first training session and 48 hours after the last training session (Week 8). Method of measurement: Blood sampling from patients.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAliReza Ahmadvand

The University of Bu Ali Sina

alireza.led@gmail.com+98 81 3825 4825

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026